Ketamine Recruiting Phase 2 Trials for Posttraumatic Stress Disorders / Post Traumatic Stress Disorder (PTSD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02655692CAP-Ketamine for Antidepressant Resistant PTSD
NCT02727998Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy